AbCellera

Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced on Tuesday it has entered into a new collaborative research agreement with AbCellera, a privately held company that has developed a high-throughput platform for the rapid discovery of therapeutic antibodies directly from natural immune...